News
Background: BIBF 1120 is a potent, orally available tyrosine kinase inhibitor (VEGFR 1/2/3, PDGFR α/β and FGFR 1/3) that suppresses tumor growth by angiogenesis inhibition. Recently, the combination ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback